Date: April 05, 2025
Classification: Frontiers
Literature Overview
This article titled 'The benefit of diet on paradoxical breathing and sleep in Osteogenesis imperfecta', published in Orphanet Journal of Rare Diseases, reviews and summarizes the vicious cycle among respiration, sleep, and nutrition in patients with Osteogenesis Imperfecta (OI). It evaluates the intervention effects of a restrictive Mediterranean diet on this cycle. By analyzing the dietary intervention outcomes in 22 OI patients, the study found that 14 compliant individuals showed improvements in weight, fat mass, thoracic tidal volume contribution, and hypopnea index, while the control group did not.
Background Knowledge
Osteogenesis Imperfecta (OI) is a hereditary connective tissue disorder primarily characterized by increased bone fragility, often accompanied by thoracic deformities, cranial abnormalities, and mandibular defects. Patients frequently suffer from imbalanced nutrition, insufficient physical activity, and obesity, which further exacerbate sleep-disordered breathing (e.g., obstructive sleep apnea, OSA) and paradoxical breathing in the supine position. Although previous studies have shown that about 30% of OI patients suffer from OSA, the potential impact of nutritional intervention on respiratory function remains underexplored. The research team previously identified disease type (Type III), neck-height ratio, and paradoxical breathing in supine position as high-risk factors for OSA, and found that patients commonly lack calcium, vitamin D, and high-quality protein intake. Therefore, this study focuses on the short-term effects of a restrictive Mediterranean diet in alleviating respiratory and sleep impairments in OI patients.
Study Methods and Design
The study employed a prospective, observational design, applying a restrictive Mediterranean diet intervention over six months to 22 adult patients diagnosed with moderate (Type I or IV) or severe (Type III) Osteogenesis Imperfecta. This diet aimed to reduce total daily caloric intake by 30%, and was enriched in plant proteins, vitamins B/D/E, ω-3 fatty acids, and polyphenols. Thoracic tidal volume contribution was assessed using opto-electronic plethysmography, and the Apnea-Hypopnea Index (AHI) was measured using portable sleep monitoring devices. Participants were categorized into a compliant group (DietOI, n=14) and a non-compliant control group (CtrOI, n=8), and changes in body weight, fat mass, respiratory function, and sleep quality were compared between the two groups.
Key Findings and Insights
Significance and Future Directions
This study provides preliminary evidence supporting the role of dietary interventions in improving respiratory function in OI patients, highlighting the importance of nutritional management in the comprehensive care of rare diseases. Future research should include larger, multicenter trials to validate the long-term effects of diet on respiratory and sleep mechanisms, and compare the applicability of different dietary patterns (e.g., Atlantic, Nordic, or plant-based diets) in OI populations. Additionally, stratified analyses based on BMI and disease severity are needed to develop more personalized nutritional strategies.
Conclusion
Patients with Osteogenesis Imperfecta often develop a vicious cycle between thoracic deformities and obesity, which exacerbates breathing and sleep disorders. The restrictive Mediterranean diet effectively disrupts this cycle by improving thoracic mechanics and reducing upper airway obstruction risk. Although this study involved a small sample size and was observational, its findings underscore the critical role of nutritional intervention in rare disease management. Future studies should expand to international multicenter collaborations to systematically assess the comprehensive impact of various dietary regimens on bone metabolism, respiratory function, and sleep quality, and work toward establishing evidence-based international dietary guidelines to enhance quality of life and reduce fracture and respiratory complication risks in OI patients.